NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer’s disease progression
Róisín M. McManus, Max P. Komes, Angelika Griep, Francesco Santarelli, Stephanie Schwartz, Juan Ramón Perea, Johannes C. M. Schlachetzki, David Bouvier, Michelle‐Amirah Khalil, Mario Lauterbach, Lea Heinemann, Titus Schlüter, Mehran Shaban Pour, Marta Lovotti, Rainer Stahl, Fraser Duthie, Juan F. Rodríguez-Alcázar, Susanne V. Schmidt, Jasper Spitzer, Peri Noori, Alberto Maillo, Andreas Boettcher, Brian Herron, John McConville, David Gómez-Cabrero, Jesper Tegnér, Christopher K. Glass, Karsten Hiller, Eicke Latz, Michael T. Heneka
Topics & Concepts
GlutaminolysisPhagocytosisBiologyDiseaseMicrogliaImmunologyAlzheimer's diseaseMicrobiologyInflammationMedicineCancerPathologyGeneticsCancer cellImmune cells in cancerTryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms